FDA widens US safety inquiry into AstraZeneca coronavirus vaccine

Posted by on September 30, 2020 6:06 pm
Categories: US National Stories

WASHINGTON – The US Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc’s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. AstraZeneca’s large, late-stage US trial has remained on hold…